SAFE vs. Convertible Note: Which to Choose for Fundraising?

Stop Saying 'Convertible Instruments'

You're raising your first round. Your advisor, lawyer, or a potential investor mentions raising on "convertible instruments." Stop them right there. This vague term groups two profoundly different fundraising tools: the SAFE (Simple Agreement for Future Equity) and the convertible note .

Yes, they both get cash in the door now without setting a firm valuation on your company. But the similarity ends there. One is a straightforward warrant to buy future stock. The other is a loan with a ticking clock that can bankrupt you.

Confusing them is a classic, and costly, rookie founder mistake. Let's make sure you don't make it.

The SAFE: The Modern Standard for Seed Funding

A SAFE, created by Y Combinator and now the standard for most U.S. tech startups, is a warrant—a contract giving the investor the right to buy equity in a future priced round. It is not debt.

It has no interest rate. · It has no maturity date (it never has to be "paid back"). · If your company fails, SAFE investors get paid back from any remaining assets only after true debt holders, but before founders.

SAFEs are defined by two main terms, and an investor gets the benefit of whichever one gives them a better price:

Valuation Cap: The maximum valuation at which the investor's money converts into equity. This rewards their early risk. If your Series A is at a $20M valuation but their SAFE had a $10M cap, they get to buy stock at the $10M price. · Discount: A percentage discount off the price of the next priced round. This also rewards early risk. A 20% discount means if Series A investors pay $1.00 per share, the SAFE investor pays $0.80 per share.

Crucial: Why You Must Use a "Post-Money" SAFE

This is the single most important detail to get right. Early SAFEs were "pre-money," which made founder dilution unpredictable. The modern standard is the "post-money" SAFE.

A post-money valuation cap means the cap is calculated after all SAFE money is added to the company's capital. This gives you, the founder, immediate clarity on how much ownership you've sold.

You raise $1M on post-money SAFEs with a $10M post-money valuation cap .

You have just sold 10% of your company (prior to the new money in the actual priced round). This lets you know precisely how much dilution you're taking on with each new SAFE you issue.

The Convertible Note: A Debt Instrument in Disguise

A convertible note is debt that is intended to convert into equity . It functions like a SAFE—with a valuation cap and a discount—but because it's a loan, it adds two dangerous terms:

Interest Rate: Typically 4-8%. This interest accrues and also converts into equity, adding to your dilution. While you don't pay it in cash, it isn't free money. · Maturity Date: This is the poison pill. It's the date the loan is due, typically 18-24 months after the investment. If you haven't raised a priced round by this date, the investor can demand their money back, plus interest.

The Maturity Date Is a Gun to Your Head

Do not underestimate the danger of a maturity date. Founders are optimistic; they assume a priced round is just around the corner. But markets turn, products slip, co-founders leave. 24 months can arrive in a blink.

If your note matures before you raise a priced round, the investor suddenly has incredible leverage. They can:

Demand repayment. For a cash-burning startup, this is a death sentence. · Force conversion at a low price. Some notes allow the holder to convert at the valuation cap, even without a priced round, potentially giving them a huge chunk of your company at a fire-sale price. · Renegotiate for harsher terms. They can offer to extend the maturity date in exchange for a lower cap, a board seat, or other concessions you would never normally give.

In a SAFE-standard market like Silicon Valley, an investor who insists on a note is either unsophisticated or is knowingly seeking the leverage that a maturity date provides. Both are red flags.

The Math: How Cap, Discount, and Dilution Really Work

Let's run the numbers. You raise $500,000 on a convertible instrument. Your terms are a $10M valuation cap and a 20% discount . One year later, you raise a Series A at a $20M pre-money valuation, with a Series A share price of $10.00.

Your early investor calculates their share price two ways and chooses the better one (the lower price):

Via Valuation Cap: Their money converts at the $10M cap, not the new $20M valuation. They effectively get to buy shares at a 50% discount to the new money. Their price per share is ~$5.00. · Via Discount: They get a 20% discount on the new price. Their price per share is $8.00 ($10.00 (1 - 0.20)).

In this scenario, the valuation cap wins. Their $500,000 buys twice as many shares as a new investor in the Series A gets for the same money. This is their reward for taking early risk.

The "SAFE Stack" Surprise

A common mistake is raising multiple SAFEs at different caps. For example: $500k at a $8M cap, then $500k at a $10M cap, then $500k at a $12M cap. This creates a "SAFE stack" or "cap waterfall."

When you go to raise your Series A, these don't average out. They convert sequentially. Your Series A lead will see a complex cap table where the first investors get a much better price than the later ones. This complexity isn't a deal-killer, but it can lead to founders being surprised by their total dilution. You a must model this out in a spreadsheet to see the impact.

Four Common, Costly Founder Mistakes

1. Flying Blind on Dilution

The Mistake: You raise on SAFEs with different caps and don't track how they will convert. When you finally get a Series A term sheet, the VC's lawyers model it for you, and you discover you own 10-15% less of the company than you thought.

How to Avoid It: From day one, maintain a simple cap table spreadsheet. Have columns for Investor , Amount , Date , Valuation Cap , and Discount . Create scenarios for your Series A (e.g., $15M, $20M, $25M pre-money) to see how your SAFE stack converts. Don't fly blind.

2. Accepting a Note in a SAFE Market

The Mistake: You're raising in a major tech hub where post-money SAFEs are standard. An investor you like insists on a convertible note. You agree, not wanting to create friction.

How to Avoid It: Recognize this for the red flag it is. An experienced, high-conviction seed investor does not need the security of debt. They are betting on massive upside, not protecting their downside. Politely but firmly hold your ground.

"For this round, we're keeping things simple and fair for all investors by using standard post-money SAFEs. We want to move fast and keep legal costs low, and using a single, standard instrument helps us do that. Can you work with a standard YC SAFE?"

3. Ignoring the Maturity Date Bomb

The Mistake: You sign a convertible note with a 24-month maturity, confident you'll raise a priced round within 18 months. You hit a product delay, and suddenly you have 3 months until maturity and no term sheet.

How to Avoid It: Just don't use convertible notes for your main seed round. If you absolutely must, negotiate for the longest possible maturity (36 months is better than 24) and language that allows a majority of noteholders to approve an extension, so one difficult investor can't hold you hostage.

4. Giving Away 'MFN' Clauses Carelessly

The Mistake: You give your first few investors a Most Favored Nation (MFN) provision, promising them the terms of any future investor who gets a better deal. Months later, to close the round, you give one strategic investor a lower valuation cap. Suddenly, you have to go back and re-price all the earlier SAFEs, causing a cascade of dilution you hadn't planned for.

How to Avoid It: Be disciplined. Set one set of terms for your entire round (e.g., "We are raising $1.5M on safes with a $12M cap."). If you must use an MFN, make sure it has a sunset provision (e.g., "this MFN provision will expire upon the closing of this round, defined as raising $1.5M, or on [Date], whichever comes first").

When Does the Standard Advice Not Apply?

While SAFEs are the default, there are specific, limited situations where convertible notes are standard practice:

Bridge Rounds: A small amount of capital raised between two priced rounds (e.g., to extend runway from Series A to Series B). The note is a short-term bridge to a known milestone. · Non-US Markets or Non-Tech Investors: In some geographies and with more traditional angel groups or family offices, convertible notes may be the only instrument their legal and financial teams understand. This is a business decision, but be aware of the trade-offs. · Distressed Scenarios: If your company is struggling, new investors may demand the seniority and security of a note to provide emergency capital.

How to Apply This Today

Download the latest post-money SAFE from Y Combinator's website. Read it. It's written in plain English and is only a few pages long. This is your baseline. · Draft the terms for your round. Decide exactly what you're raising and on what terms (e.g., "$1M on post-money SAFEs with a $10M valuation cap and a 20% discount"). Write this down. Consistency is your friend. · Build your cap table model. Use a spreadsheet to model your SAFE stack and project your founder ownership after the SAFEs convert and the Series A is raised. Know your numbers cold. · Rehearse your pushback. Practice the script for why you are only using post-money SAFEs for this round. Be polite, confident, and firm.

Choosing your fundraising instrument is one of the first major decisions you'll make. By insisting on post-money SAFEs, you are signaling that you are a sophisticated founder, protecting your ownership, and setting a clean, fair foundation for your relationship with every investor.